| | 1092939-17-7 Basic information More.. |
| Product Name: | Ruxolitinib phosphate | | Synonyms: | (betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile phosphate;INCB 018424;Ruxolitinib, Phosphate;(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile phosphoric acid;Ruxolitinib (INCB-18424) phosphate;Jakafi (ruxolitinib);Ruxolitinib phosphate, >=98%;RUXOLITINIB(INCB018424) PHOSPHATE | | CAS: | 1092939-17-7 | | MF: | C17H21N6O4P | | MW: | 404.37 | | EINECS: | | | Mol File: | 1092939-17-7.mol |  |
Use
The phosphate salt of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
- Ruxolitinib Phosphate
-
- 2026-06-12
- CAS:1092939-17-7
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Ruxolitinib phosphate
-
- $2.00
- 2026-04-10
- CAS:1092939-17-7
- Min. Order: 1KG
- Purity: 99% hplc
- Supply Ability: 500TONS
|
|
1092939-17-7
Recommend Suppliers |
|